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In adenovirus-12 tumorigenic cells, the viral E1A-12 protein mediates transcriptional down-regulation of the major histocompatibility complex
(MHC) class I genes by targeting the class I enhancer. Here, we demonstrate by a combination of antisense and chromatin immunoprecipitation
(ChIP) analysis that E1A-12 is a physical component of the class I enhancer repression complex, known to comprise COUP-TFII and histone
deacetylase 1 (HDAC1). Significantly, E1A antisense was shown to co-eliminate E1A-12 as well as HDAC1 and HDAC8, but not HDAC3, from
the enhancer repression complex. Consistent with elimination of HDAC1 and HDAC8, E1A antisense also resulted in a dramatic increase in
histone acetylation, a hallmark of transcriptionally active chromatin. Importantly, MHC class I antigen expression was restored on the surface of
E1A antisense-transfected cells. These results demonstrate that E1A-12 is associated with the MHC class I complex and apparently mediates class
I transcriptional down-regulation by enacting chromatin repression through HDAC1 and HDAC8.
© 2006 Elsevier Inc. All rights reserved.Keywords: Adenovirus-12 E1A; MHC class I expression; HDACs; COUP-TFII; Transcriptional repressionIntroduction
Cell surface major histocompatibility complex (MHC) class
I antigens are major determinants for cell-mediated immune
surveillance performed by cytotoxic T lymphocytes (CTLs). A
diminution of cell surface MHC class I antigens serves to
increase the tumorigenic potential of adenovirus type 12 (Ad12)
transformed cells by enabling them to avoid CTL detection
(Yewdell et al., 1988). E1A of Ad12 (E1A-12) is the sole viral
protein responsible for the transcriptional down-regulation of all
MHC class I genes (Vasavada et al., 1986). The MHC class I
enhancer contains independent binding sites for activator NF-
κB (R1 site) and for nuclear hormone receptors (R2 site)
(Kimura et al., 1986). A dual mechanism accounts for the block⁎ Corresponding author. Department of Microbiology, School of Dental
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doi:10.1016/j.virol.2006.04.036of MHC class I transcription in Ad12 transformed cells (Hou et
al., 2002). First, the activator NF-κB (p50/p65 heterodimer) fails
to bind to the R1 enhancer DNA due to hypo-phosphorylation of
the p50 subunit (Kushner and Ricciardi, 1999; Hou et al., 2003;
Guan et al., 2005). Second, COUP-TFII, an orphan nuclear
hormone repressor, binds to the R2 enhancer site where it
complexes with N-CoR and HDAC proteins, resulting in
deacetylation of histones (Kralli et al., 1992; Liu et al., 1994;
Smirnov et al., 2000; Smirnov et al., 2001). We have suggested
that both of these E1A-12 mediated mechanisms involving loss
of activator NF-κB and gain of repressor HDAC1/COUP-TFII
provides a “fail-safe”mechanism to ensure that the transcription
of class I genes remains strongly down-regulated under varying
physiological conditions (Hou et al., 2002).
Since E1A-12 is the only viral protein responsible for the
down-regulation of the MHC class I enhancer (Vasavada et al.,
1986), it is reasonable to speculate that E1A-12 interacts with the
repression complex bound to the enhancer. In our previous
study, we used chromatin immunoprecipitation (ChIP) assay to
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MHC class I enhancer complex (Zhao et al., 2003). The
informative value of the ChIP assay is that it can identify proteins
that do not directly bind to DNA, such as E1A-12. Briefly, in the
ChIP assay, proteins that bind DNA directly or indirectly are
cross-linked in vivo, the DNA is sheared and antibodies that
target specific proteins are used to isolate the cross-linked DNA,
which can then be identified by PCR amplification using specific
oligonucleotides. This permits the study of protein–DNA
interactions in a physiological environment, which is otherwise
not possible using other in vitro assays such as EMSA.
In this study, we employ an antisense gene knockdown
approach in combination with a ChIP assay, to show that E1A-
12 and HDAC1 and HDAC8 are co-residents of the MHC class
I transcriptional repression complex. Significantly, antisense
knockdown of E1A-12 co-eliminates these HDACs from the
repression complex and their abilities to down-regulate class I
transcription and cell surface antigen expression.
Results
E1A-12 can be eliminated from the MHC class I enhancer
complex
We employed an antisense approach to determine whether
elimination of E1A-12 from the MHC class I enhancer
repression complex could relieve down-regulation of MHC
class I gene expression. We utilized two phosphorothioate
antisense oligonucleotides capable of annealing to Ad12 E1A
mRNA in order to disrupt production of the full-length 266
amino acid E1A-12 protein (Fig. 1A). The first E1A oligonu-
cleotide (antisense-1, 3′-279CCCGCTTACATACGG-Fig. 1. E1A-12 antisense abolishes synthesis of E1A-12 protein. (A) Depicted is the
mRNA. Antisense-1 oligocnucleotide hybridizes to nucleotides 279–300, which ta
Antisense-2 oligocnucleotide hybridizes to nucleotides −10 to 10 which spans the 5′
region. (B) Immunoprecipitation of E1A-12. Twenty hours after transfection with an
with [35S]-methionine and cell lysates were immunoprecipitated with E1A-12 antise
translation was used as a marker to verify the IP band (not shown). Coomassie blue s
Western blot of E1A-12. COS-7 cells were co-transfected with an E1A-12 protein exp
hpi cell lysates were examined by Western blot. As an internal control, an expression
shown are representatives of multiple independent experiments.TGTTGAC300-5′) targeted E1A codons 93–100 (Fig. 1A).
Antisense-1 oligonucleotide was transfected with oliogofecta-
mine (InVitrogen) into the Ad12 tumorigenic cell line 12A1. The
12A1 cells are well characterized and are representative of the
various types of cell lines transformed by Ad12 (Reviewed in
Williams et al., 2004). Following transfection (20 h), the 12A1
cells were incubated with 35[S]-methionine (2 h) in order to
observe only newly synthesized E1A-12 proteins and avoid the
large background pool of pre-existing E1A-12 proteins. Lysates
from labeled cells were immunoprecipitated with E1A-12
antisera (Scott et al., 1984), separated on a protein gel and
visualized by autoradiography. As shown in Fig. 1B, synthesis
of E1A-12 protein was substantially inhibited by the antisense
oligonucleotide as compared to the nonsense oligonucleotide. It
is noted that since the transfection efficiency is less than 100%,
some of the labeled E1A-12 protein seen in the antisense-1
oligonucleotide transfected lysate is from cells that failed to take
up antisense-1 oligonucleotide. Therefore, the actual level of
inhibition within the antisense-1 transfected 121A cells is
predictably greater than that observed in Fig. 1B.
In order to substantiate this result, we tested the capability of
antisense-1 to block E1A-12 synthesis in COS-7 cells that lack
E1A-12. The E1A-12 antisense-1 oligonucleotide was co-
transfected with a CMV promoter-driven E1A expression vector
into COS-7 cells and after 20 h, cell lysates were analyzed by
western blot using E1A antisera as the probe. One advantage of
employing co-transfection is that it ensures that most of the cells
will contain sequences for both the E1A expression vector and
the antisense oligonucleotide. As shown in Fig. 1C, antisense-1
dramatically inhibited E1A-12 protein synthesis in COS-7 cells.
By contrast, the nonsense oligonucleotide failed to inhibit E1A-
12 protein synthesis. Moreover, an internal control expressionlocation of the two E1A-12 antisense oligonucleotides in relation to the E1A-12
rgets codons 93–100 of the E1A-12 266 amino acid coding region (boxed).
non-coding region and the first several nucleotides of the E1A-12 mRNA coding
tisense-1 or nonsense E1A-12 oligonucleotides, 12A1 cells were labeled for 2 h
ra and visualized by autoradiography (top). E1A12 protein produced by in vitro
tain of cell lysates used to verify equal protein loading the lysates (bottom). (C)
ression vector and E1A-12 antisense and nonsense oligonucleotides and after 20
plasmid encoding the NF-κB p50 was included in each co-transfection. Results
Fig. 3. Transfection of E1A-12 antisense oligonucleotides results in acetylation
of histones associated with the MHC class I enhancer. In ChIP assays, anti-
acetyl-histone antibody was used to immunoprecipitate sonicated chromatin
from antisense-1 or antisense-2 or nonsense transfected 12A1 cells. The MHC
class I enhancer was amplified by PCR and resolved on an agarose gel. The
input of 1% indicates that an equal amount of sonicated chromatin from
antisense and control nonsense-transfected cells was used. Results shown are
representative of multiple independent experiments.
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was not affected by antisense-1.
We next inquired whether this inhibition of cellular E1A-12
synthesis by the antisense-1 oligonucleotide would also result in
loss of E1A-12 as a component of the MHC class I enhancer
complex (Zhao et al., 2003). The chromatin immunoprecipita-
tion (ChIP) assay is ideal for this type of analysis, since the
presence of non-DNA binding E1A-12 protein can be monitored
by PCR amplification of the MHC class I enhancer region with
which E1A-12 associates as a component of the complex that
includes the transcriptional repressor, HDAC1, and the DNA
binding protein, COUP-TFII (Zhao et al., 2003; Smirnov et al.,
2000). E1A-12 antisense-1 and control nonsense oligonucleo-
tides were transfected into 12A1 cells. After 20 h, the 12A1 cells
were cross-linked with formaldehyde, sonicated, and immuno-
precipitated with E1A-12-specific antisera. MHC class I
enhancer DNA associated with the E1A-12 immunoprecipitated
complex was eluted by reverse-cross-linking at 65 °C, amplified
by PCR with primers flanking the MHC class I enhancer region
(Zhao et al., 2003) and visualized on an agarose gel. As inferred
from Fig. 2 (lanes 1 and 2), E1A-12 remained as a component of
theMHC class I enhancer complex only in the control nonsense-
transfected cells, but not in the antisense-1 transfected cells.
For this study, a second and distinct E1A-12 antisense
oligonucleotide (antisense-2, 5′-10CAGTTCTCATAATGGCG
CCG10-3′) as shown in Fig. 1A was used in the ChIP assay.
Antisense-2 spans the 5 region and the first 10 nucleotides of the
coding region of E1A-12 mRNA, serving to prevent initiation of
translation. As seen in Fig. 2 (lanes 3 and 4), antisense-2
oligonucleotide also prevented PCR amplification of the MHC
class I enhancer, confirming that this effect is due to the targeted
loss of E1A-12 and not to indiscriminate interference of non-
targeted gene products. These results firmly establish that E1A-
12 is an integral member of the repression complex.
Elimination of E1A-12 from the enhancer complex results in
histone acetylation
We have previously shown that in Ad12 transformed cells,
repression of MHC class I transcription is due to histone
deacetylation by HDACs that associate with the MHC class IFig. 2. Immunoprecipitation of the class I enhancer by E1A-12 antisera is
prevented by E1A antisense-1 oligonucleotides. A Chip analysis was performed
with sonicated chromatin from 12A1 cells that were transfected with antisense-1
or antisense-2 or nonsense oligonucleotides and immunoprecipitated with anti-
Ad12 E1A antisera. The MHC class I enhancer was amplified by PCR and
resolved on agarose gel. For each ChIP analysis, 1% of the sonicated chromatin
was amplified to verify that an equal input was used for E1A immunoprecip-
itation with both the antisense and nonsense samples. Results shown are
representative of multiple independent experiments.enhancer through an interaction with the DNA binding
protein, COUP-TFII (Smirnov et al., 2000; Zhao et al.,
2003). Significantly, histone acetylation of the MHC class I
enhancer following treatment of 12A1 cells with TSA, an
HDAC inhibitor, provided compelling evidence that HDACs
actively repress MHC class I transcription. These former
findings (Smirnov et al., 2000; Zhao et al., 2003) and above
results (Fig. 2) imply that, as a component of the MHC class I
repression complex, E1A-12 mediates down-regulation of
class I transcription by enlisting HDACs. To demonstrate this,
we first examined changes in histone acetylation after
eliminating E1A-12 from the MHC class I enhancer. Histone
acetylation in antisense- and nonsense-transfected 12A1 cells
was analyzed by the ChIP assay using anti-acetyl-histone
antibody. Indeed, acetylation of histones was dramatically
increased in 12A1 cells transfected with either E1A-12
antisense-1 or antisense-2 oligonucleotides, as determined by
the increase in the PCR signal obtained with DNA that was
immunoprecipitated with acetyl-histone antibody (Fig. 3). By
contrast, in 12A1 cells that had been transfected with nonsense
oligonucleotides there was no amplification of MHC class I
enhancer DNA that was co-immunoprecipitated with acetyl-
histone antibody (Fig. 3).
Elimination of E1A-12 co-eliminates HDACs from the
enhancer complex
We next examined whether the increase in histone
acetylation observed with E1A-12 antisense-1 and antisense-
2 oligonucleotides (Fig. 3) is accompanied by loss of specific
HDACs from the MHC complex. To test for this, we
performed ChIP assays that employed antibodies against the
group of HDACs that are involved in transcriptional
regulation, i.e., HDAC1, 2, 3, and 8 (Reviewed in Sengupta
and Seto, 2004). As seen in Fig. 4, HDAC1, HDAC3 and
HDAC8 apparently reside in the MHC class I enhancer
complex, as indicated by the strong PCR signals obtained in
12A1 cells transfected with the control E1A nonsense
oligonucleotide. By comparison, only marginal levels of
HDAC2 are present (Fig. 4, nonsense lane). Interestingly,
when the 12A1 cells were transfected with the E1A antisense-
1 oligonucleotide, HDAC1 and HDAC8, but not HDAC3,
Fig. 4. HDAC1 and HDAC8 reside in the MHC class I enhancer repression
complex. 12A1 cells were transfected with antisense-1 or nonsense oligonu-
cleotides from which equal amounts of sonicated chromatin were immunopre-
cipitated with anti-HDAC1, -HDAC2, -HDAC3, or -HDAC8 antibodies. The
MHC class I enhancer was amplified by PCR and resolved on an agarose gel.
The input of 1% indicates that an equal amount of sonicated chromatin from
antisense and control nonsense-transfected cells was used. Results shown are
representative of multiple independent experiments.
Fig. 5. HDAC1 and HDAC8 are eliminated from the MHC class I enhancer
repression complex by E1A antisense oligonucleotides. 12A1 cells were
transfected with antisense-1 or antisense-2 or nonsense oligonucleotides from
which chromatin was isolated, sonicated and immunoprecipitated with anti-
HDAC1 or anti-HDAC8 antibodies. The MHC class I enhancer was amplified
by PCR and resolved on an agarose gel. The input of 1% indicates that an equal
amount of sonicated chromatin from antisense and control nonsense-transfected
cells was used. Results shown are representative of multiple independent
experiments.
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(Fig. 4, antisense-1 lanes). To confirm that the presence of
HDAC1 and HDAC8 in the MHC class I enhancer complex is
dependent on E1A-12, the 12A1 cells were transfected with
the E1A antisense-1 and antisense-2 oligonucleotides, respec-
tively, and analyzed in the ChIP assay. As seen in Fig. 5, both
E1A antisense-1 and antisense-2 oligonucleotides effectively
eliminated HDAC1 and HDAC8 from the MHC class I
enhancer complex. These findings imply that HDAC1 and
HDAC8 are dependent on Ad12 E1A to deacetylate histones
and repress MHC class I transcription.
E1A-12 antisense restores cell surface levels of MHC Class I
antigens
Loss of MHC class I surface antigens is a physiological
consequence of E1A-12 protein expression in Ad12 tumori-
genic cells (Vasavada et al., 1986). Since the E1A antisense
oligonucleotides resulted in the elimination of HDAC1 and
HDAC8 proteins from the MHC class I enhancer complex
(Figs. 4 and 5) with a concomitant increase in acetylation of the
MHC class I enhancer DNA (Fig. 3), we anticipated that
introduction of E1A-12 antisense into Ad12-tumorigenic cells
should restore MHC class I expression. To address this, FACS
analyses were performed on 12-1 cells transfected with either
E1A-12 antisense-1 oliogonucleotide or a nonsense oliogonu-
cleotide and the MHC class I cell surface antigen levels were
measured using anti-rat MHC class I MAb (clone OX-18,
Cedarlane Laboratories (Smirnov et al., 2000). Indeed, as seen
in the Fig. 6, the 12-1 cells transfected with E1A-12 antisense
oligonucleotide displayed a marked increase in levels of MHC
class I cell surface antigens as compared to nonsense
oligonucleotide transfected cells and non-transfected cells. It
is noted that there was a greater amount of MHC class I surface
expression observed with the nonsense oligonucleotide trans-
fected cells vs. the non-transected cells. This likely represents a
cellular response generated by the oligonucleotide transfection
procedure per se, and as such, the nonsense oligonucleotide
transfected cells should be considered the more relevant
baseline to evaluate the increase in MHC class I expression
observed with the E1A-12 antisense oligonucleotide.Discussion
The E1A-12 protein is the sole viral product responsible for
the shutdown of the MHC class I transcription in tumorigenic
Ad12 transformed cells (Vasavada et al., 1986). We have
previously shown that the MHC class I enhancer is the target of
E1A-12 mediated down-regulation of class transcription (Ge et
al., 1992). This down-regulation involves lack of binding of
activator NF-κB to the R1 site of the enhancer (Liu et al., 1996)
and binding of repressor COUP-TFII to the R2 site of the
enhancer (Liu et al., 1994). It has long been questioned whether
E1A-12 exerts its function directly by associating with the
MHC class I enhancer repression complex or indirectly e.g., via
signal transduction. In our previous study, we showed that E1A-
12 is an integral component of the COUP-TFII repression
complex that binds to the MHC class I enhancer (Zhao et al.,
2003). We had also shown that histone deacetylation is involved
in class I repression by demonstrating that the levels of MHC
class I antigens increase on the cell surface following treatment
with TSA, an HDAC inhibitor (Smirnov et al., 2000; Hou et al.,
2002).
In this study, we asked if there is a clear link between the
existence of E1A-12 in the class I COUP-TFII enhancer
repression complex and the histone deacetylation activity that is
associated with class I transcriptional down-regulation. The
results of this study reveal that HDAC1 and HDAC8
specifically reside in the class I COUP-TFII repression complex
where their presence and function is completely dependent on
the presence of E1A-12. Elimination of E1A-12 from the
complex by the use of antisense oligonucleotides resulted in the
co-elimination of HDAC1 and HDAC8. Significantly, this
elimination of HDAC1 and HDAC8 by E1A-12 was accom-
panied by an increase in both chromatin acetylation of the MHC
class I enhancer and by expression of MHC class I antigens on
the cell surface.
Although the physical presence of HDAC1 and HDAC8 in
the enhancer repression complex are dependent on the co-
presence of E1A-12 in the same complex, we were not able to
detect a direct interaction between E1A-12 with HDACs in
Fig. 6. Surface levels of MHC class I antigens are elevated in 12-1 cells transfected with E1A-12 antisense oligonucleotide. FACS analysis of 12-1 cells transfected
with E1A-12 antisense-1 or nonsense oligonucleotides was performed using monoclonal antibodies against rat MHC class I antigens. The results are representative of
multiple independent experiments.
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antibodies against E1A-12 and HDACs (Zhao and Ricciardi,
unpublished). It is conceivable that E1A-12 recruits or stabilizes
the HDACs in the R2 enhancer repression complex through
another ‘linker’ protein. Future studies will resolve whether
such a putative linker protein is novel or is a known member of
the COUP-TFII repression complex e.g., COUP-TFII, N-CoR
and SMRT (Smirnov et al., 2000; Shibata et al., 1997), p300
(Bailey et al., 1998) or possibly CTIP1 or CTIP2 (Avram et al.,
2000).
It is important to note that there are at least 18 HDACs
(Thiagalingam et al., 2003). However, the possible number and
combinations of these HDACs in any one-transcription
complex is unclear. HDAC1 and HDAC8 belong to the group
of HDACs that are ubiquitously expressed, reside in nuclei, and
form associations with the classical co-repressors of transcrip-
tion, i.e., Sin3 and N-CoR. In an earlier study (Zhao et al.,
2003), we had shown that HDACs -4, -5, -6, and -7 can also be
found in the MHC class I repression complex. This latter group
of HDACs exhibit tissues specificity, reside both in the
cytoplasm and nuclei, and, in the case of HDACs -4, -5, and
-7, are included in specific containing SMRT, N-CoR and
HDAC3 complexes (Thiagalingam et al., 2003). However, our
preliminary findings indicate that HDACs -4, -5, and -7 are not
affected by E1A antisense. A possible E1A-antisense affect
with HDAC6, which has yet to be confirmed, could be
particularly interesting considering the fact that, while impor-tant in transcriptional regulation (Cho et al., 2005), this HDAC
also acts as a microtubule associated deacetylase, (Hubbert et
al., 2002; Iwata et al., 2005).
In summary, this study provides the first demonstration that
the E1A-12 oncoprotein co-resides with HDAC1 and HDAC8
in the R2-repression complex of the MHC class I enhancer.
Significantly, chromatin repression by the HDACs is depen-
dent upon the existence of E1A-12 in the R2 complex. This
ability of Ad12 E1A to mediate repression of MHC class I
transcription through HDACs accounts for the loss of MHC
class I antigen expression on the cell surface and ultimately for
the capacity of Ad12 tumorigenic cells to escape CTL
recognition and lysis.
Materials and methods
Cells and antibodies and antisense oligonucleotides
Mouse Ad12-transformed cell line 12A1 was previously
described (Eager et al., 1985). Antibodies against COUP-TFII
and 13S Ad12 E1Awere previously described (Liu et al., 1994;
Scott et al., 1984). Anti-HDAC antibodies and anti-acetyl-
histone antibodies were purchased from Upstate Biotech
(Waltham, MA). The E1A antisense oligonucleotides were
obtained from Molecula (Columbia, MD). The sequence of the
E1A antisense-1 oligonucleotide is 5′-cagttgtggcatacattcgccc-
3′, which hybridizes to nucleotides 279 to 300 of E1A-12
343B. Zhao, R.P. Ricciardi / Virology 352 (2006) 338–344mRNA. The sequence of E1A antisense-2 oligonucleotide is 5′-
cagttctcataatggcgccg-3′, which hybridizes to nucleotides -10 to
10 of E1A-12 mRNA.
Metabolic labeling and immunoprecipitation
The Ad12-tumorigenic cell line 12A1 was transfected with
either an E1A antisense or nonsense oligonucleotide using
oligofectamine (Invitrogen, CA). After 20 h, transfectants
were rinsed with PBS, and then fresh methionine-free DMEM
medium (4 ml) together with 200 μCi of 35[S]-methionine was
added to a 10-cm dish. After 2-h incubation, labeled cells were
washed with PBS, collected and lysed by freeze/thaw cycles in
PBS. Cell lysates in 0.5 ml of PBS were immunoprecipitated
with E1A-12 antiserum overnight at 4 °C. Protein A agarose
beads were added and then washed 5× with PBS before
addition of protein loading buffer. Immunoprecipitation
products were analyzed by SDS-PAGE and exposure to X-
ray film.
ChIP assay
Chip Assays were performed as previously described (Zhao
et al., 2003). Essentially, cells from one 10 cm dish
(approximately 1.5×107 cells) were cross-linked by adding
formaldehyde directly into the culture media to a final
concentration of 1% and incubated at room temperature for
10 min. Media was removed and cells were rinsed twice with
PBS, scraped in PBS, and pelleted. Cell pellets were
resuspended in 0.1 ml of the lysis buffer (Upstate Biotech),
followed by addition of 0.4 ml of the dilution buffer (Upstate
Biotech). Cell lysates (1 ml) were sonicated 12 times for 30 s
each, at an energy level of 30% using a Sonifier Cell Disruptor
(Branson Sonic Power Inc., Danburg, CT). For ChIP assays
performed with anti-acetyl-histone antibody, cell lysates were
sonicated only twice for 5 s each. Sonicated chromatin samples
were centrifuged for 2 min in a microcentrifuge. Supernatants
(0.5 ml) were immunoprecipitated with antibodies and rotated at
4 °C for a minimum of 3 h. Sixty microliters of protein-A
agarose beads (50% slurry) were added to the supernatants and
rotated for 30 min. The beads were then rinsed briefly in the low
salt buffer (Biotech), washed for 5 min each in the high salt
buffer and the LiCl buffer (Upstate Biotech), and finally rinsed
briefly in TE. Immunoprecipitates were then resuspended in
0.5 ml of TE and 50 μl of 2 M NaCl and DNA was eluted by
reverse cross-linking at 65 °C for a minimum of 1 h with
occasional agitation. Eluted DNAwas extracted with 0.5 ml of
phenol/chloroform and ethanol-precipitated. DNA pellets were
resuspended in 50 μl of water and were amplified by PCR. To
demonstrate equal input of sonicated chromatin used in the
ChIP assays, 1% of sonicated chromatin before immunopre-
cipitation was examined.
PCR amplification
The forward PCR primer (5′-GGGTTCAGGCAAAGTCT-
TAG-3′) represents − 211 to − 231 of the mouse H2Kd promoterregion. The reverse PCR primer (5′-GACCTGACCCAGGT-
TAGGTG-3′) represents and 118 to − 138 of the mouse H2Kd
promoter region. After 30 cycles, PCR reaction products (25 μl)
were resolved on a 1% agarose gel.
FACS analysis
FACS analysis were performed on a Becton Dickinson
FACStarplus as previously described (Eager et al., 1985). Anti-
rat MHC class I monoclonal antibody RT1.A (OX-27) was
purchased from Cedarlane Laboratories (Ontario, Canada).
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